Sambrinvest logo

Sambrinvest

Crunchbase
Pitchbook
Crunchbase

Deals on record

2

Common Fundraising Type

Equity

ATB Therapeutics is a biologics company developing therapeutic antibodies with novel cell-killing mechanisms for oncology and immunology therapies.

Series A
$57.1M
11/19/2024
Article

AdipoPharma is a biotech company developing a novel insulin sensitizer to treat Type 2 diabetes by targeting adipocytes to address insulin resistance.

Equity
Undisclosed
11/12/2024
Article